Latest filing published 12 Aug 2026 for TAKEDA PHARMACEUTICAL CO LTD, €740k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Filings by Teresa Marie Bitetti span 2 companies, the busiest being Takeda Pharmaceutical Co Ltd and Aura Biosciences, Inc. The record holds 5 filings, for trades running from 31 March 2025 to 10 August 2026.
Sales make up the whole of the open-market record (1 sale, €740k). Besides market trades, the filings include 4 share grants. 2026 to date brings no purchases and 1 sale.
The record was last updated on 12 August 2026 with an open-market sale (€740k) in Takeda Pharmaceutical Co Ltd. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations